Medical

US FDA Ruling Confirms PFAS Fluoropolymers in Medical Devices Are Safe

Hardlines, Medical /

Geneva (September 4, 2025) – SGS, the world’s leading testing, inspection and certification company, has published SafeGuardS 125.25, reporting on the US Food and Drug Administration’s (FDA) review of per- and polyfluoroalkyl substances (PFAS) fluoropolymers in medical devices. The FDA has announced the results of a review finding no conclusive evidence of patient care issues […]

US FDA Ruling Confirms PFAS Fluoropolymers in Medical Devices Are Safe Read More »

DEHP Regulated in Certain Medical Devices in North Carolina, USA

Hardlines, Medical /

Geneva (August 21, 2025) – SGS, the world’s leading testing, inspection and certification company, has published SafeGuardS 119.25, summarizing North Carolina’s ban on di(2-ethylhexyl) phthalate (DEHP) in intravenous (IV) bags and tubing. SB 600 (session law 2025-60) was signed on July 3, 2025, regulating DEHP in IV solution containers and tubing. This amendment adds Article

DEHP Regulated in Certain Medical Devices in North Carolina, USA Read More »

GLP-1 Research and Regulatory Insights Webinar for the Nutra Industry

Medical /

SGS, the world’s leading testing, inspection and certification company, is delighted to present a complimentary webinar, ‘The GLP-1 craze decoded: current research and regulatory insights for the nutra industry,’ on February 27, 2025. Hormone-focused solutions for appetite modulation and weight management, such as GLP-1, are attracting significant attention within the nutraceutical industry. As market opportunities

GLP-1 Research and Regulatory Insights Webinar for the Nutra Industry Read More »

SGS introduces first commercial cell sorting service for the biopharmaceutical industry in Germany

Medical /

SGS, the world’s leading testing, inspection and certification company, is proud to announce the launch of Germany’s first commercial cell sorting service via fluorescent-activated cell sorting (FACS) for the biopharmaceutical industry. This groundbreaking service leverages the advanced BD FACSAria™ Fusion system to support the development of advanced therapeutic medicinal products (ATMPs) and drive innovation in

SGS introduces first commercial cell sorting service for the biopharmaceutical industry in Germany Read More »

SGS Investigates MedTech Cybersecurity Challenges

Connectivity, Medical /

SGS, the world’s leading testing, inspection and certification company, has published a Consumer Compact article examining the dangers posed by cyberattacks on medical technologies (MedTech). Healthcare providers and patients are benefiting from an expanding range of digital technologies, which can enhance diagnosis, monitoring, treatment and care. Alongside these advances, the healthcare sector is increasingly facing

SGS Investigates MedTech Cybersecurity Challenges Read More »

SGS laboratory in Cork, Ireland, supports sustainability goals of pharmaceutical clients with recently awarded platinum My Green Lab certification

Medical /

SGS, the world’s leading testing, inspection and certification company, is proud to announce that its laboratory in Ringaskiddy, Cork, Ireland, has received platinum certification under the My Green Lab verification program. Pharmaceutical businesses looking to improve their sustainability credentials can now confidently partner with SGS, knowing they are working with a laboratory that is not

SGS laboratory in Cork, Ireland, supports sustainability goals of pharmaceutical clients with recently awarded platinum My Green Lab certification Read More »

SGS expands cutting-edge spray drug delivery testing capabilities in Belgium health science laboratory

Medical /

SGS, the world’s leading testing, inspection and certification company, has announced an expansion in its spray drug delivery testing capabilities at their laboratory in Wavre, Belgium. Utilizing the latest Malvern Spraytec system, SGS can now accurately measure droplet size in real-time during the spraying event, typically occurring within a fraction of a second. In line

SGS expands cutting-edge spray drug delivery testing capabilities in Belgium health science laboratory Read More »

DEHP Banned in Some Medical Devices in California

Hardlines, Medical /

SGS, the world’s leading testing, inspection and certification company, has published SafeGuardS 152.24 on California’s prohibition of Di-(2-ethylhexyl) phthalate (DEHP) in intravenous solution containers (IV bags) and IV tubing. AB 2300 was signed into law on September 25, 2024, making California the first US jurisdiction to restrict ortho-phthalates in medical devices. DEHP is an ortho-phthalate that

DEHP Banned in Some Medical Devices in California Read More »

SGS Announces Expansion of Biopharmaceutical Testing Capabilities

Medical /

Geneva, Switzerland (October 7, 2024) – SGS, the world’s leading testing, inspection and certification company, is pleased to announce that it has added new capacity and capabilities at its center of excellence in Lincolnshire, Illinois, USA. This expansion adds new instrumentation and expertise to a substantial and well-established facility which currently provides outsourcing services to

SGS Announces Expansion of Biopharmaceutical Testing Capabilities Read More »

SGS’s Shanghai Health Science Laboratory completes US FDA inspection with zero 483 observations

Medical /

SGS, the world’s leading testing, inspection and certification company, has set a new benchmark for third-party pharmaceutical testing laboratories in China following an outstanding inspection by the US Food and Drug Administration (FDA) of its Shanghai Health Science Laboratory. For a third consecutive time, the facility was not issued a Form FDA 483 at the

SGS’s Shanghai Health Science Laboratory completes US FDA inspection with zero 483 observations Read More »

Scroll to Top